Machine-learning–driven biomarker discovery for the discrimination between allergic and irritant contact dermatitis
Contact dermatitis tremendously impacts the quality of life of suffering patients. Currently, diagnostic regimes rely on allergy testing, exposure specification, and follow-up visits; however, distinguishing the clinical phenotype of irritant and allergic contact dermatitis remains challenging. Empl...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 52; pp. 33474 - 33485 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
29-12-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Contact dermatitis tremendously impacts the quality of life of suffering patients. Currently, diagnostic regimes rely on allergy testing, exposure specification, and follow-up visits; however, distinguishing the clinical phenotype of irritant and allergic contact dermatitis remains challenging. Employing integrative transcriptomic analysis and machine-learning approaches, we aimed to decipher disease-related signature genes to find suitable sets of biomarkers. A total of 89 positive patch-test reaction biopsies against four contact allergens and two irritants were analyzed via microarray. Coexpression network analysis and Random Forest classification were used to discover potential biomarkers and selected biomarker models were validated in an independent patient group. Differential gene-expression analysis identified major gene-expression changes depending on the stimulus. Random Forest classification identified CD47, BATF, FASLG, RGS16, SYNPO, SELE, PTPN7, WARS, PRC1, EXO1, RRM2, PBK, RAD54L, KIFC1, SPC25, PKMYT, HISTH1A, TPX2, DLGAP5, TPX2, CH25H, and IL37 as potential biomarkers to distinguish allergic and irritant contact dermatitis in human skin. Validation experiments and prediction performances on external testing datasets demonstrated potential applicability of the identified biomarker models in the clinic. Capitalizing on this knowledge, novel diagnostic tools can be developed to guide clinical diagnosis of contact allergies. |
---|---|
Bibliography: | Author contributions: D.G., H.A., and N.F. designed research; V.F., L.W., P.W., S.S., E.J., A.S., M.K., M.P., A.L., K.A.-K., and N.F. performed research; V.F., N.L., V.M., M.K., and J.L. contributed new reagents/analytic tools; V.F., L.W., P.W., D.G., and N.F. analyzed data; V.F., L.W., P.W., and N.F. wrote the paper; S.S., E.J., M.P., A.L., and K.A.-K. recruited patients; S.S., E.J., and M.P. sampled patch test reactions; S.S. evaluated patch test reactions; A.L. and K.A.-K. sampled patients; and S.S., E.J., M.P., A.L., and K.A.-K. commented on the manuscript. 1V.F. and L.W. contributed equally to this work. Edited by Smita Krishnaswamy, Yale University, New Haven, CT, and accepted by Editorial Board Member Ruslan Medzhitov November 10, 2020 (received for review May 8, 2020) |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.2009192117 |